A New Dancing Partner for Venetoclax: Gilteritinib von Fathi, Amir T

Volltext

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia von Stein, Eytan M., DiNardo, Courtney D., Pollyea, Daniel A., Fathi, Amir T., Roboz, Gail J., Altman, Jessica K., Stone, Richard M., DeAngelo, Daniel J., Levine, Ross L., Flinn, Ian W., Kantarjian, Hagop M., Collins, Robert, Patel, Manish R., Frankel, Arthur E., Stein, Anthony, Sekeres, Mikkael A., Swords, Ronan T., Medeiros, Bruno C., Willekens, Christophe, Vyas, Paresh, Tosolini, Alessandra, Xu, Qiang, Knight, Robert D., Yen, Katharine E., Agresta, Sam, de Botton, Stephane, Tallman, Martin S.

Volltext

Glasdegib with Low-Dose Cytarabine: A New Upfront Option for the Vulnerable AML Patient von Fathi, Amir T

Volltext

Mechanisms of Ion Transport in Lithium Salt-Doped Polymeric Ionic Liquid Electrolytes von Zhang, Zidan, Nasrabadi, Amir T, Aryal, Dipak, Ganesan, Venkat

Volltext

On Bayesian credibility mean for finite mixture distributions von Jahanbani, Ehsan, Payandeh Najafabadi, Amir T., Masoumifard, Khaled

Volltext

Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion von Su, Rui, Dong, Lei, Li, Yangchan, Gao, Min, Han, Li, Wunderlich, Mark, Deng, Xiaolan, Li, Hongzhi, Huang, Yue, Gao, Lei, Li, Chenying, Zhao, Zhicong, Robinson, Sean, Tan, Brandon, Qing, Ying, Qin, Xi, Prince, Emily, Xie, Jun, Qin, Hanjun, Li, Wei, Shen, Chao, Sun, Jie, Kulkarni, Prakash, Weng, Hengyou, Huang, Huilin, Chen, Zhenhua, Zhang, Bin, Wu, Xiwei, Olsen, Mark J., Müschen, Markus, Marcucci, Guido, Salgia, Ravi, Li, Ling, Fathi, Amir T., Li, Zejuan, Mulloy, James C., Wei, Minjie, Horne, David, Chen, Jianjun

Volltext

Bioactivity Potential of EndoSequence BC RRM Putty von Moinzadeh, Amir T., DDS, MSc, Aznar Portoles, Carlos, DDS, MSc, Schembri Wismayer, Pierre, MD, PhD, Camilleri, Josette, BCHD, MPhil, PhD, FADM, FIMMM

Volltext

Pevonedistat, a new partner for 5-azacitidine von Fathi, Amir T.

Volltext

The role of FLT3 inhibitors in the treatment of FLT3‐mutated acute myeloid leukemia von Fathi, Amir T., Chen, Yi‐Bin

Volltext

Targeting CD70 in acute myeloid leukaemia: an emerging therapeutic angle in combinatorial treatment von Fathi, Amir T

Volltext

Characterization of Leachates from 6 Root Canal Sealers von Elyassi, Yasaman, Moinzadeh, Amir T., Kleverlaan, Cornelis J.

Volltext

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML von Perl, Alexander E, Martinelli, Giovanni, Cortes, Jorge E, Neubauer, Andreas, Berman, Ellin, Paolini, Stefania, Montesinos, Pau, Baer, Maria R, Larson, Richard A, Ustun, Celalettin, Fabbiano, Francesco, Erba, Harry P, Di Stasi, Antonio, Stuart, Robert, Olin, Rebecca, Kasner, Margaret, Ciceri, Fabio, Chou, Wen-Chien, Podoltsev, Nikolai, Recher, Christian, Yokoyama, Hisayuki, Hosono, Naoko, Yoon, Sung-Soo, Lee, Je-Hwan, Pardee, Timothy, Fathi, Amir T, Liu, Chaofeng, Hasabou, Nahla, Liu, Xuan, Bahceci, Erkut, Levis, Mark J

Volltext

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, p... von DiNardo, Courtney D, Schuh, Andre C, Stein, Eytan M, Montesinos, Pau, Wei, Andrew H, de Botton, Stéphane, Zeidan, Amer M, Fathi, Amir T, Kantarjian, Hagop M, Bennett, John M, Frattini, Mark G, Martin-Regueira, Patricia, Lersch, Frederik, Gong, Jing, Hasan, Maroof, Vyas, Paresh, Döhner, Hartmut

Volltext

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark von Taylor, Justin, Haddadin, Michael, Upadhyay, Vivek A., Grussie, Erwin, Mehta-Shah, Neha, Brunner, Andrew M., Louissaint, Abner, Lovitch, Scott B., Dogan, Ahmet, Fathi, Amir T., Stone, Richard M., Tallman, Martin S., Rampal, Raajit K., Neuberg, Donna S., Stevenson, Kristen E., Horwitz, Steven M., Lane, Andrew A.

Volltext

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia von Roboz, Gail J., DiNardo, Courtney D., Stein, Eytan M., de Botton, Stéphane, Mims, Alice S., Prince, Gabrielle T., Altman, Jessica K., Arellano, Martha L., Donnellan, Will, Erba, Harry P., Mannis, Gabriel N., Pollyea, Daniel A., Stein, Anthony S., Uy, Geoffrey L., Watts, Justin M., Fathi, Amir T., Kantarjian, Hagop M., Tallman, Martin S., Choe, Sung, Dai, David, Fan, Bin, Wang, Hongfang, Zhang, Vickie, Yen, Katharine E., Kapsalis, Stephanie M., Hickman, Denice, Liu, Hua, Agresta, Samuel V., Wu, Bin, Attar, Eyal C., Stone, Richard M.

Volltext

Emergence of crenolanib for FLT3-mutant AML von Fathi, Amir T.

Volltext

The effect of reinsurance treaties on the cedent loss reserving von Payandeh Najafabadi, Amir T., Atatalab, Fatemeh

Volltext

Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective von Kantarjian, Hagop, Zeidan, Amer M, Fathi, Amir T, Stein, Eytan, Rajkumar, Vincent, Tefferi, Ayalew

Volltext

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib von Stein, Eytan M., DiNardo, Courtney D., Fathi, Amir T., Pollyea, Daniel A., Stone, Richard M., Altman, Jessica K., Roboz, Gail J., Patel, Manish R., Collins, Robert, Flinn, Ian W., Sekeres, Mikkael A., Stein, Anthony S., Kantarjian, Hagop M., Levine, Ross L., Vyas, Paresh, MacBeth, Kyle J., Tosolini, Alessandra, VanOostendorp, Jason, Xu, Qiang, Gupta, Ira, Lila, Thomas, Risueno, Alberto, Yen, Katharine E., Wu, Bin, Attar, Eyal C., Tallman, Martin S., de Botton, Stéphane

Volltext

C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis von Mohd Amin, Amir T., Zaki, Rafdzah A., Friedmacher, Florian, Sharif, Shazia P.

Volltext